Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.
Among patients who have suffered a single stroke, researchers at the University of Pennsylvania School of Medicine, along with colleagues at other institutions, have found that severe stenosis, or narrowing, of the arteries in the head represents a major risk factor for the development of a subsequent stroke.
In a study of more than 3,000 older Australians, those with a higher white blood cell count, a sign of inflammation, were more likely to die of cancer, according to an article in the January 23 issue of Archives of Internal Medicine.
Aspirin is typically prescribed for people at risk of having an ischemic stroke to prevent blood clots. Because aspirin may cause bleeding, it is typically avoided in people who have had a hemorrhagic stroke, also called intracerebral hemorrhage.
A study from the Stroke Service at Massachusetts General Hospital (MGH) has found that some patients who have survived an intracerebral hemorrhage - a stroke caused by bleeding in the brain - may be safely treated with aspirin to prevent future heart attacks or strokes caused by blood clots.
Rush University Medical Center is the first site in Illinois to use the first stent specifically designed for use in the brain. While it has been possible to attempt to open narrowed brain vessels using existing stents made of stainless steel and intended for use in the heart, the new Wingspan brain stent is designed to be gentler on the more fragile brain vessels.
Researchers have found in an analysis of previous studies, that the use of aspirin significantly reduces the risk of cardiovascular events in women and in men.
Aspirin can significantly reduce the risk of cardiovascular events -- a combined endpoint including stroke, heart attack and death due to cardiovascular disease -- in both men and women, according to a new meta-analysis of more than 95,000 patients by a Duke University Medical Center cardiologist.
An analysis of previous studies indicates that use of aspirin significantly reduces the risk of cardiovascular events in women and in men, due to reducing the risk of stroke in women and reducing the risk of heart attack in men, according to a study in the January 18 issue of JAMA: The Journal of the American Medical Association.
A new report says that although people with coronary artery disease (CAD) are now more likely to use evidence-based therapies than they were a few years ago, there is still room for improvement.
Nearly half the coronary artery disease (CAD) patients in a seven-year study admitted they don’t consistently take beta blockers, cholesterol-lowering drugs and other medications that could extend their lives, researchers report in Circulation: Journal of the American Heart Association.
Older Americans with alcohol problems do not get worse treatment than their sober peers when they are hospitalized for a heart attack, according to new research on Medicare patients across the country.
Aspirin can significantly reduce death rates for postmenopausal women with cardiovascular disease (CVD), researchers reported at the American Heart Association's Scientific Sessions 2005.
The U.S. Food and Drug Administration's (FDA) historically sound reputation could be in jeopardy due to it's possibly too close relationship with the major pharmaceutical companies.
Patients with mental health problems may not be receiving the appropriate screening or treatments for illnesses including heart disease and stroke, a report from The University of Nottingham has shown.
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
An analysis of the treatment received by more than 100,000 heart patients has shown that physicians' prescription practices for drugs proven effective for treating heart disease has shown steady improvement over the past three years, cardiologists at the Duke Clinical Research Institute (DCRI) have concluded.
Aspirin has long been hailed as one of the most effective, low-cost ways to help guard against a heart attack or stroke. However, international medical researchers caution that low doses of aspirin also increase a patient's chance of developing an ulcer, often without warning signs.
Survey results released by the American College of Preventive Medicine (ACPM) found that nearly half (48%) of U.S. adults 40+ with diabetes are not utilizing aspirin therapy to reduce their risk of recurrent heart attack or stroke nor had they reported discussing such therapy with their healthcare provider.
After one year - Get With The GuidelinesSM programs used in hospitals significantly improved care for almost 30,000 coronary artery disease patients of all ages and sexes, according to research reported at the American Heart Association's Scientific Sessions 2005.
A meta-analysis of more than 95,000 patients has shown that aspirin can significantly reduce the risk of stroke in women, but it appears to have no protective effect in men, according to a new analysis by Duke University Medical Center cardiologists.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.